共 26 条
- [1] Wilcox, Olsson, Skene, Et al., Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian study of early thrombolysis (ASSET), Lancet, 2, pp. 525-530, (1988)
- [2] Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)., Lancet, 1, pp. 397-402, (1986)
- [3] Verstraete, Bory, Collen, Et al., Randomized trial of intravenous recombinant tissue-type plasminogen activator versus streptokinase in acute myocardial infarction. ECSG, Lancet, 1, pp. 842-847, (1985)
- [4] Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group., Lancet, 2, pp. 349-360, (1988)
- [5] Cerqueirs, Litwin, Martin, Et al., Infarct size reduction and preservation of ejection fraction with very early thrombolytic treatment for myocardial infarction
- [6] radionuclide results from the Myocardial Infarction Triage and Intervention Trial, Circulation, 86, (1992)
- [7] GISSI, Longterm effects of intravenous thrombolysis in acute myocardial infarction: A final report of the GISSI study, Lancet, 2, pp. 871-874, (1987)
- [8] Koren, Weiss, Hasin, Et al., Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase, N Engl J Med, 313, pp. 1384-1389, (1985)
- [9] Fine, Weiss, Sapoznikov, Et al., Importance of early initiation of intravenous streptokinase therapy for acute myocardial infarction, Am J Cardiol, 58, pp. 411-417, (1986)
- [10] Kereiakes, Weaver, Anderson, Et al., Time delays in the diagnosis and treatment of acute myocardial infarction: A tale of eight cities, Report from the PreHospital Study Group and the Cincinnati Heart Project, 120, pp. 773-780, (1990)